Home > Insider Trading > Filing (0001179110-18-010845)

Filing Details

Accession Number:: 0001179110-18-010845
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-08-23 18:58:54
Reporting Period:: 2018-06-19

Accepted Time:: 2018-08-23 18:58:54
Original Submission Date:: 2018-06-19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926326	Omnicell Inc	OMCL	Electronic Computers (3571)	943166458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1227556	A Randall Lipps	C/O Omnicell, Inc. 590 E.middlefield Mountain View CA 94043	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-06-19	9,483	$52.04	191,265	No	4	S	Direct
Common Stock	Acquisiton	2018-06-19	18,154	$0.00	209,419	No	4	M	Direct
Common Stock	Disposition	2018-06-19	18,154	$52.00	191,265	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options NQ (right to Buy)	Disposition	2018-06-19	18,154	$0.00	18,154	$25.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,154	2015-02-04	2025-02-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	200,748	Direct
Common Stock	361,701	Indirect	In Trust with Wife
Common Stock	14,549	Indirect	In Trust for Children

Footnotes

Shares held in trust with Mr. Lipps' wife.
Shares held in trust for the benefit of Mr. Lipps' children.
The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.
The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This amendment is being filed to correct the balance of shares held in trust with the reporting person's wife. This balance was incorrectly reported as 393,228 shares; however, the correct balance is 361,701 shares. As originally reported in a Form 4 filed on June 20, 2017, the reporting person sold 31,527 shares from this trust on June 19, 2017 pursuant to a Rule 10b5-1 trading plan. However, due to an administrative error, this reported sale was not correctly reflected in the balance of shares held in this trust in all Form 4s filed by the reporting person following the sale from July 28, 2017 through June 20, 2018.
Reflects a transfer of 1,000 shares in June 2018 from this trust directly to the reporting person's child (who is no longer a minor) as the reporting person no longer has a reportable beneficial interest in such shares.
This reflects the correct starting balance of directly owned shares which was incorrectly reported due to an administrative error in the original Form 4,filed on June 20, 2018.